Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
October 23, 2009
IN THIS ISSUE
Counterfeit medicines concerns
FDA drug labeling guidance
Generics prevent innovation
CROs united
More...

Counterfeit medicines more profitable than heroin
The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs, which the group is particularly concerned about. More...

FDA new guidance on drug labeling and pharmacologic classification
The FDA has issued a guidance for industry and review staff titled, 'Labeling for Human Prescription Drug and Biological Products — Determining Established Pharmacologic Class for Use in the Highlights of Prescribing Information'. More...

Generics prevent innovations in pharma
Cheaper generic pharmaceuticals, emboldened by US law and patent challenges, restrict novel future innovations, according to researchers. More...

Uniting all CROs
US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help companies get products to market faster by establishing an international network of CROs. More...

Pfizer and Wyeth begin operations as a combined company
Following the completion of its $68-billion acquisition of Wyeth, Pfizer has begun operations at the new combined company. More...

Webcast: Solving the Challenges of Adaptive Clinical Trials: The keys to improving efficiency for every study
This webinar discusses best practices for implementing the right kinds of adaptations strategically and responsibly, resulting in faster, more efficient trials. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Key Topic Updates
November events
Drug Master Files (DMFs) — Understanding and Meeting Your Regulatory and Processing Responsibilities (5–6 November | Germany)
Manufacturing Sterile Products (5 November | UK)
Active Pharmaceutical Ingredients (18–20 November | Italy)
More events
 
Latest blog posts
Equality for boys?
CPhI Worldwide conference coverage: ISP launches drug-solubility initiative
Understanding QbD requires basic fundamentals
More blog posts
 
Latest formulation articles
Formulation and evaluation of Famotidine floating matrix tablets
Defining the ideal properties of a moisture protective, instant release film coating
Developing robust formoterol-containing suspension pMDIs with enhanced shelf lives
More formulation articles

Key Topic Updates

Survey
How would you characterize the current market for contract manufacturing for small-molecules?
  Poor 9%
  Flat 22%
  Fair 34%
  Moderate 19%
  Strong 16%

This week we would like to know...

Is FDA's initiative to better inform the public of what it does the right step for the agency?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.